1. Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status Blagoev, Krastan B.; Wilkerson, Julia; Burotto, Mauricio; Kim, Chul; Espinal-Dominguez, Edward; Garcia-Alfonso, Pilar; Alimchandani, Meghna; Miettinen, Markku; Blanco-Codesido, Montserrat; Fojo, Antonio Tito 2017 Articles Drug resistance in cancer cellsApoptosisColon (Anatomy)--CancerTumors--Growth
2. Promoter Methylation-Mediated Inactivation of PCDH10 in Acute Lymphoblastic Leukemia Contributes to Chemotherapy Resistance Narayan, Gopeshwar; Freddy, Allen J.; Xie, Dongxu; Liyanage, Hema; Clark, Lorraine N.; Kisselev, Sergey; Kang, Ji Un; Nandula, Subhadra; McGuinn, Catherine; Subramaniyam, Shivakumar; Alobeid, Bachir; Satwani, Prakash; Savage, David G.; Vundavalli, Murty V. 2011 Articles EpigeneticsLymphoblastic leukemiaPromoters (Genetics)MethylationDrug resistance in cancer cells
3. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia? Subramaniyam, Shivakumar; Nandula, Subhadra; Nichols, G.; Weiner, Michael A.; Satwani, Prakash; Alobeid, Bachir; Bhagat, Govind; Vundavalli, Murty V. 2006 Articles LeukemiaLeukemia--TreatmentDrug resistance in cancer cellsGene fusionGenetics